Coeptis Therapeutics
Coeptis Therapeutics is a clinical stage biotechnology company developing innovative cell therapy platforms for patients with cancer and other debilitating diseases. It focuses on the development and acquisition of pharmaceutical products. Its pipeline is evolving from the partnerships being created with multiple pharmaceutical companies. As the relationships unfold, the product pipeline will be updated accordingly.
Domain
coeptistx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$4.0M
Founded
2016
Tech Stack (1 technologies)
Frequently Asked Questions
What technologies does Coeptis Therapeutics use?+
Coeptis Therapeutics uses 1 technologies including Google Font API.
What industry is Coeptis Therapeutics in?+
Coeptis Therapeutics operates in the Biotechnology industry.
Where is Coeptis Therapeutics based?+
Coeptis Therapeutics is headquartered in United States.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026